Gossamer Bio’s $212 Million Private Placement Financing

Latham & Watkins represented Gossamer Bio in the transaction.Gossamer Bio, Inc. (Nasdaq: GOSS) announced that it has entered into a securities purchase agreement with institutional and…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Pietro Martinoia

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here